Skip to main content


Figure 1 | BMC Neuroscience

Figure 1

From: Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke

Figure 1

ATP activity and trypan blue assay in cultured neurons and astrocytes. ATP activity was measured to reveal cell viability with varying concentrations of minocycline or vehicle. OGD condition reduced ATP activity of cultured neurons to 40% of non-OGD control group (A). Low doses of minocycline (0.001 to 10 μM) preserved cell viability of neurons (A), but not astrocytes (B). In contrast, high dose of minocycline (100 μM) displayed toxicity to both neurons and astrocytes (A, B). In parallel with ATP assay, Trypan blue assay revealed that low doses of minocycline (0.001-10 μM) exerted neuroprotective effects on cultured neurons, but not astrocytes (C-G: neurons, H-L: astrocytes, C, H: non-OGD control, D, I: 0 μM, E, J: 1 μM, F, K: 100 μM of minocycline). High dose of minocycline (100 μM) displayed toxicity for both neurons and astrocytes. Data are shown as mean values ± SEM (*p < 0.05 increase and **p < 0.05 decrease vs. vehicle-treated cultured neurons or astrocytes; A, G: neurons, B, L: astrocytes). Scale bar: 25 μm.

Back to article page